Glenmark Pharmaceuticals receives six observations after US FDA inspection of Goa plant
Pharma major Glenmark Pharmaceuticals Ltd on Tuesday (June 30) said the US Food and Drug Administration (US FDA) has issued six observations following a Good Manufacturing Practices (GMP) inspection of its manufacturing facility in Goa.The inspection was conducted between June 22 and June 30, 2026…